New Results
High-level expression of STING restricts susceptibility to HBV by mediating type III IFN induction
View ORCID ProfileHiromichi Dansako, Hirotaka Imai, Youki Ueda, Shinya Satoh, Kunitada Shimotohno, Nobuyuki Kato
doi: https://doi.org/10.1101/375782
Hiromichi Dansako
1Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Hirotaka Imai
1Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Youki Ueda
1Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Shinya Satoh
1Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Kunitada Shimotohno
2Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan
Nobuyuki Kato
1Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Article usage
Posted July 24, 2018.
High-level expression of STING restricts susceptibility to HBV by mediating type III IFN induction
Hiromichi Dansako, Hirotaka Imai, Youki Ueda, Shinya Satoh, Kunitada Shimotohno, Nobuyuki Kato
bioRxiv 375782; doi: https://doi.org/10.1101/375782
Subject Area
Subject Areas
- Biochemistry (11573)
- Bioengineering (8623)
- Bioinformatics (28874)
- Biophysics (14805)
- Cancer Biology (11944)
- Cell Biology (17170)
- Clinical Trials (138)
- Developmental Biology (9306)
- Ecology (14022)
- Epidemiology (2067)
- Evolutionary Biology (18129)
- Genetics (12148)
- Genomics (16619)
- Immunology (11709)
- Microbiology (27697)
- Molecular Biology (11392)
- Neuroscience (60106)
- Paleontology (447)
- Pathology (1849)
- Pharmacology and Toxicology (3184)
- Physiology (4878)
- Plant Biology (10279)
- Synthetic Biology (2849)
- Systems Biology (7291)
- Zoology (1619)